RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xtant Medical Holdings Stock

Xtant Medical Holdings P/S 2024

Xtant Medical Holdings P/S

0.77

Ticker

XTNT

ISIN

US98420P3082

WKN

A2JDJS

As of Dec 28, 2024, Xtant Medical Holdings's P/S ratio stood at 0.77, a -10.47% change from the 0.86 P/S ratio recorded in the previous year.

The Xtant Medical Holdings P/S history

Xtant Medical Holdings Aktienanalyse

What does Xtant Medical Holdings do?

Xtant Medical Holdings Inc. is a leading provider of medical technology and biologics, specializing in the development, manufacturing, and marketing of innovative orthopedic solutions to support patients. The company was founded in 2013 and is headquartered in Belgrade, Montana, USA. The company is focused on two main divisions: Xtant Medical and Xspine Systems. Xtant Medical specializes in the development and sale of orthopedic implants and biologics for use in spinal, sports medicine, and extremity surgery. Xtant Medical's product range includes bone replacement substitutes such as allografts, synthetic bone graft products, autologs, and matrix. Xtant Medical's products are developed and distributed by an experienced and dedicated team of physicians, engineers, and scientists who are focused on delivering innovative products of the highest quality and safety. Xspine Systems specializes in the development of innovative surgical instruments and implants for spinal surgery. Xspine Systems' product range includes implants for the lumbar spine (LWS), cervical spine (HWS), and thoracic spine (TWS), as well as surgical instruments such as kits, drills, screws, and plates. Xspine Systems' products are characterized by excellent quality and innovation, enabling surgeons to provide precise and effective treatments for their patients. Xtant Medical has a strong focus on research and development. The company has an experienced team of scientists, engineers, and surgeons who are dedicated to developing innovative solutions for the most complex medical challenges. The company has extensive research and development programs that focus on the development of high-quality implants and biologic solutions for spinal, sports medicine, and extremity surgery. The company's products are based on scientific studies that are based on evidence-based principles to ensure they meet the needs of patients and surgeons. Xtant Medical is always striving to meet the needs of its customers by providing high-quality products and services. The company has adhered to the highest quality standards and procedures to ensure that its products meet the requirements of the industry. The company works closely with surgeons and clinicians to ensure that the products meet the requirements of surgeons and the needs of patients. Xtant Medical is a leading provider of medical technology and biologics, specializing in the development, manufacturing, and marketing of innovative orthopedic solutions to support patients. The company has earned an excellent reputation for its high-quality products and services and is constantly striving to exceed the expectations of its customers. Xtant Medical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Xtant Medical Holdings's P/S Ratio

Xtant Medical Holdings's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Xtant Medical Holdings's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Xtant Medical Holdings's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Xtant Medical Holdings’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Xtant Medical Holdings stock

What is the price-to-earnings ratio of Xtant Medical Holdings?

The price-earnings ratio of Xtant Medical Holdings is currently 0.77.

How has the price-earnings ratio of Xtant Medical Holdings changed compared to last year?

The price-to-earnings ratio of Xtant Medical Holdings has increased by -10.47% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Xtant Medical Holdings high compared to other companies?

Yes, the price-to-earnings ratio of Xtant Medical Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of Xtant Medical Holdings affect the company?

An increase in the price-earnings ratio of Xtant Medical Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Xtant Medical Holdings affect the company?

A decrease in the price-earnings ratio of Xtant Medical Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Xtant Medical Holdings?

Some factors that influence the price-earnings ratio of Xtant Medical Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Xtant Medical Holdings pay?

Over the past 12 months, Xtant Medical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xtant Medical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Xtant Medical Holdings?

The current dividend yield of Xtant Medical Holdings is .

When does Xtant Medical Holdings pay dividends?

Xtant Medical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xtant Medical Holdings?

Xtant Medical Holdings paid dividends every year for the past 0 years.

What is the dividend of Xtant Medical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xtant Medical Holdings located?

Xtant Medical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xtant Medical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xtant Medical Holdings from 12/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/28/2024.

When did Xtant Medical Holdings pay the last dividend?

The last dividend was paid out on 12/28/2024.

What was the dividend of Xtant Medical Holdings in the year 2023?

In the year 2023, Xtant Medical Holdings distributed 0 USD as dividends.

In which currency does Xtant Medical Holdings pay out the dividend?

The dividends of Xtant Medical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xtant Medical Holdings

Our stock analysis for Xtant Medical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xtant Medical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.